If you want to join DOGE don't bother sending Elon Musk your CV, just DM a few bullet points to the department on X.

Armed with $115 million and a clinical-stage asset, another player is emerging in the increasingly crowded T cell engager ...

In mechanobiology, cells' forces have been considered fundamental to their enhanced function, including fast migration. But a ...

A recent Cell Reports paper by the Oxenius group (IMB) demonstrates a function of targeted centrosome inheritance during CD8+ ...

Russell W. Jenkins, MD, Ph.D., a physician investigator in the Krantz Family Center for Cancer Research at the Mass General ...

Like workers at a factory or office, proteins in a cell must be in the right department to do their jobs. But scientists have ...

Cullinan offers promising oncology and autoimmune products, strong financials, and potential for growth, making it a ...

Large language models may unlock a new and valuable type of research.

A clinical-stage biotechnology company will advance a novel autologous chimeric antigen receptor T-cell therapy that targets ...

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

A newly identified cartilage cell generates fat vacuoles and makes the surrounding tissues pliable. This helps keep the ear ...

In a study published today in the Journal of Clinical Investigation, Fred Hutch Cancer Center cancer chemical biologist ...